Jan.13 — Xie Dong, chairman and chief science officer of Frontier Biotechnologies, a Chinese clinical-stage drug developer that focuses on HIV treatments, discusses the company’s business, outlook and its plan to list shares. He speaks on the sidelines of UBS Greater China Conference with Tom Mackenzie on “Bloomberg Markets: China.” …read more
Source:: Yahoo Finance
